Lipid-lowering drugs, dyslipidemia, and breast cancer risk in a Medicare population.

Catherine SchairerD Michal FreedmanShahinaz M GadallaRuth M Pfeiffer

Published in: Breast cancer research and treatment (2018)

Lipid-lowering drugs did not account for the lower breast cancer risk associated with dyslipidemia. Our data do not support using statins or other lipid-lowering drugs to prevent breast cancer.

Keyphrases

breast cancer risk
fatty acid
cardiovascular disease
electronic health record
drug induced
big data
type diabetes
artificial intelligence
deep learning
health insurance
data analysis
affordable care act